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Esophageal Location. Background: The esophagus may be mobile during a left atrial (LA) ablation
procedure for atrial fibrillation (AF).
Objective: The goal of the study was to determine whether the location of the esophagus is stable in
patients undergoing a repeat LA ablation procedure.
Methods: Forty-two patients underwent repeat LA ablation a mean of 7 ± 2 months after the initial
procedure. Cinefluoroscopic images of the esophagus during a barium swallow were recorded and the
course of the esophagus was tagged on the 3D map. The position of the esophagus at the index and repeat
procedure were compared.
Results: At the index procedure, the esophagus was located near the left pulmonary veins (PVs) in 20
(48%), right PVs in 13 (31%), and at the mid LA in 9 (21%) patients. During the repeat procedure, the
esophagus was found to be near the left PVs in 22 (52%), right PVs in 11 (26%), and at the mid LA in
9 patients (21%). In 35 of the 42 patients (83%), there was no change in the esophageal location, and in the
remaining seven patients (17%), its position had shifted by ≥1 cm (range 1.0–4.0 cm).
Conclusions: In more than 80% of patients presenting for a repeat LA ablation procedure, the esophagus
is in the same position relative to the PVs as during the initial procedure. Therefore, if radiofrequency
ablation at a particular location was limited by the position of the esophagus, safe ablation at that site is
unlikely to be feasible during a repeat procedure. (J Cardiovasc Electrophysiol, Vol. 19, pp. 351-355, April
2008)
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A serious complication of radiofrequency catheter abla-
tion of atrial fibrillation (AF) is esophageal injury and the
formation of an atrio-esophageal (AE) fistula.1,2 One strat-
egy to reduce the risk of this complication is to avoid the
posterior left atrium (LA) immediately over the esophagus.
This approach requires real-time imaging of the esophagus
during the ablation procedure. The location of the esopha-
gus may limit successful ablation,3 resulting in arrhythmia
recurrences and repeat procedures. As the esophagus may be
a mobile structure,4 it is possible that it would be at a differ-
ent location during the repeat procedure, thereby allowing a
critical area to be safely ablated.
The purpose of this study was to compare the position of
the esophagus relative to the PVs and posterior LA in patients
who underwent two ablation procedures.
Methods
Patient Characteristics
Forty-two consecutive patients underwent a repeat abla-
tion procedure for either AF (16) or atypical atrial flutter (26)
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a mean of 7 ± 2 months after an initial AF ablation proce-
dure. There were 29 men and 13 women. Their mean age,
left ventricular ejection fraction, and left atrial (LA) diame-
ter were 57 ± 9 years, 0.54 ± 0.09, 43 ± 8 mm, respectively.
Prior to the first procedure, AF had been paroxysmal in 30
patients (71%) and persistent in 12 patients (21%). Twelve of
the 42 patients (29%) had structural heart disease, including
hypertension with left ventricular hypertrophy in six, coro-
nary artery disease in three, dilated cardiomyopathy in one,
hypertrophic cardiomyopathy in one, and repair of an atrial
septal defect in one.
Ablation Procedure for AF
Patients with a history of persistent AF underwent trans-
esophageal echocardiography prior to the procedure to rule
out intracardiac thrombi. The ablation procedure for AF was
guided by an electroanatomic mapping system (CARTO,
Biosense-Webster, Diamond Bar, CA, USA). A 3D replica
of the LA and tubular models of the PVs were created. The
PV ostia were identified by a combination of venography,
real-time impedance,5 characteristics of the local electro-
grams, and fluoroscopy. In 29 of 42 study patients (69%),
circumferential PV ablation was performed at the initial ses-
sion.6 Briefly, circumferential lesions were deployed around
the left- and right-sided PVs, along with linear ablation at
the posterior wall and mitral isthmus. After AE fistula was
described,1 the posterior line was either omitted or moved
to the most cranial aspect of the roof. Six patients (14%)
underwent LA ablation that targeted complex, fractionated
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Figure 1. An esophagram obtained during a
barium swallow in a patient undergoing an
ablation procedure for recurrent atrial fibril-
lation (AF). The white arrows highlight the
course of the esophagus, which is located to-
ward the right-sided pulmonary veins (PV).
The red and yellow arrows point to the abla-
tion catheter and a ring catheter in the right
superior PV, respectively. LAO = left anterior
oblique.
electrograms.7 Seven patients (17%) underwent a hybrid ap-
proach consisting of both circumferential PV ablation and
complex, fractionated electrogram abaltion.
Radiofrequency energy was delivered using a 8-mm-tip
ablation catheter (Navistar, Biosense Webster) with temper-
ature and power settings of 50–55◦C and 50–60 W, respec-
tively. The endpoint was reduction of the amplitude of the
local electrogram by >80% or to less than 0.1 mV. In patients
who underwent electrogram-guided ablation, radiofrequency
energy was delivered until voltage abatement as above, or or-
ganization of the local electrogram. Procedural endpoints also
included conversion of AF to sinus rhythm, or elimination of
all sites with complex electrograms within the LA.
Rhythm-control medications were prescribed for 6–12
weeks in patients with persistent AF. Rate-control medica-
tions were prescribed for patients with paroxysmal AF. Pa-
tients were monitored overnight and were discharged on sub-
cutaneous low-molecular-weight heparin for 5 days and war-
farin. Patients were seen in follow-up at 3 and 6 months, and
as clinically indicated thereafter.
Mapping and Ablation of Atypical Atrial Flutter
The PV ostia were identified as described above. Atyp-
ical atrial flutter was mapped with activation mapping us-
ing an electroanatomic mapping system (CARTO; Biosense-
Webster) and entrainment mapping. Radiofrequency energy
was delivered at sites within the reentry circuit and extended
to anatomic barriers or areas with conduction block. Catheter
ablation was performed using an 8-mm-tip catheter (Navi-
Figure 2. A: An electroanatomical map in a
PA view in a patient undergoing catheter abla-
tion of AF. The esophagus (pink tags) lies near
the ostia of the left-sided pulmonary veins. B:
An electroanatomical map from the same pa-
tient as in panel A showing that the course
of the esophagus is preserved during a repeat
procedure 6 months later. LS = left superior;
LI = left inferior; RS = right superior; RI =
right inferior.
star, Biosense-Webster) with the same temperature and power
settings as for AF, or an 3.5-mm irrigated-tip catheter (Ther-
mocool, Biosense-Webster) with a power setting of 25–35 W
and a temperature cut-off of 45◦C. The postprocedure care
and follow-up were the same as after ablation of AF except
that rhythm-control medications were only prescribed if the
procedure was unsuccessful.
Imaging of the Esophagus
After creation of the electroanatomical map of the LA, a
barium swallow was performed prior to conscious sedation.
Patients were asked to swallow 5 cc of barium paste (E-Z-
Paste, E-Z-EM Canada Inc., Westbury, NY, USA). Cinefluo-
roscopic images were recorded during the barium swallow in
an anteroposterior and left anterior oblique (45◦) projections
(Fig. 1). An esophagram was recorded only after the patient
had completely swallowed the bolus of barium, because deg-
lutition itself may alter esophageal dimensions. The ablation
catheter was then moved to the portion of the LA that was
overlying the esophagus as visualized on the esophagram.
The alignment of the ablation catheter with the esophagus
was then confirmed in multiple fluoroscopic views. After
catheter stability was confirmed for 5 seconds, the course
of the esophagus was then “tagged” on the electroanatomic
map. These steps were performed at three levels to deter-
mine the esophageal course with respect to the superior, mid,
and inferior LA (Fig. 2). General anesthesia was not used
in any of the patients. There were no instances of barium
aspiration.
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Figure 3. Panels A and B show that the
course of the esophagus at the first (A) and
second (B) ablation procedures is the same,
adjacent to the ostia of the right-sided PVs.
The two ablation procedures were separated
by 9 months.
Analysis of the Position of the Esophagus
The electroanatomical maps from the 1st and 2nd abla-
tion procedures were compared off-line by one investigator
(R.K.). To minimize bias, the two 3D maps per patient were
not analyzed sequentially. The position of the esophagus was
classified as being adjacent to the left- or right-sided PVs or
along the middle portion of the posterior LA. The distance
between the esophagus and the ostia of the PVs was mea-
sured on the electroanatomical maps. Specifically, a vertical
line was drawn connecting the ostial points of the ipsilateral
PVs. Then, the distance from the middle of this line to the
corresponding esophageal point was determined. A shift in
location of the esophagus was considered to be significant
if the esophagus at the time of the second ablation proce-
dure was positioned ≥1.0 cm away from its location dur-
ing the first ablation procedure. LA volume was also deter-
mined from the maps obtained from both the first and second
ablation procedures using an automated function (CARTO,
Biosense-Webster).
Statistical Analysis
Continuous variables are expressed as mean ± one stan-
dard deviation and were compared using a paired t-test. Cate-
gorical variables were compared by a two-sided Fisher exact
test. A P-value <0.05 indicated statistical significance.
Results
Eighty-four electroanatomical maps from 42 patients were
analyzed in order to compare the position of the esophagus.
The LA volumes determined from the first and second elec-
troanatomical maps were 134 ± 41 mL and 118 ± 35 mL,
respectively (P = 0.001). At least a 10% reduction in LA
volume was noted in 24 of the 42 patients (57%). During the
first ablation procedure, the esophagus was located near the
left PVs in 20 patients (48%) (Fig. 2), near the right PVs in
13 patients (31%) (Fig. 3), and along the mid-portion of the
posterior LA in 9 patients (21%). During the second ablation
procedure, the esophagus was located near the left PVs in
22 patients (52%), near the right PVs in 11 patients (26%),
and along the mid-portion of the posterior LA in nine pa-
tients (21%). Quantitatively, the esophagus was positioned a
mean of 23.8 ± 13.5 mm from the ostia of the left PVs dur-
ing the first procedure, compared to a mean of 24.6 ± 15.9
mm during the second procedure (P = 0.7). The esophagus
was positioned a mean of 41.6 ± 13.8 mm from the ostia of
the right PVs during the first procedure, compared to a mean
of 41.7 ± 14.0 mm during the second procedure (P = 1.0)
(Table 1).
In 35 of 42 patients (83%), there was no shift in the po-
sition of the esophagus. In the other seven patients (17%),
the esophagus shifted by at least ≥1 cm (range 1.0–4.0 cm)
(Figs. 4 and 5). Specifically, the esophagus shifted to the left-
and right-sided PVs in five and two patients, respectively.
A transesophageal echocardiogram was performed before
the second ablation procedure in 29 of 42 patients (69%).
A shift in the position of the esophagus was not related to
whether or not a transesophageal echocardiogram had been
performed (P = 0.7). Further, a shift in esophageal location
was not related to a reduction in LA volume (P = 0.7).
Discussion
Main Findings
The main finding of this study is that the relationship of
the esophagus with respect to the LA is unchanged during
two ablation procedures separated by a mean of 7 months in
>80% of patients. Therefore, although the esophagus may be
mobile during the course of an AF ablation procedure,4 it ap-
pears to have a resting position in the posterior mediastinum
that typically remains constant. These findings demonstrate
that if the position of the esophagus limits the safe delivery
of radiofrequency energy during an AF ablation procedure,
a second ablation procedure at a later time is likely to be met
with the same limitation.
Esophageal Mobility
At first, it may seem difficult to reconcile the fact that the
esophagus is “acutely” mobile during an ablation procedure,
and also that its location is preserved in patients presenting
for a repeat ablation procedure several months later. The re-
sults of the current study suggest that the esophagus has a
TABLE 1
Esophageal Location with Respect to the Pulmonary Veins at the First and
Second Ablation Procedure
1st (mm) 2nd (mm) P-value
Eso-LPV 23.8 ± 13.5 24.6 ± 15.9 0.7
Eso-RPV 41.6 ± 13.8 41.7 ± 14.0 1.0
“Eso-LPV” and “Eso-RPV” refer to the distance between the esophagus
and left- and right-sided pulmonary veins, respectively; “1st” and “2nd”
refer to the first and second ablation procedures.
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Figure 4. An example of esophageal shift. A:
The esophagus was coursing near the ostia
of the right-sided PVs during the initial abla-
tion procedure. B: During the repeat ablation
procedure 7 months later, the esophagus was
near the left-sided PVs, representing a shift of
4 cm.
relatively stable course in the posterior mediastinum, which
seems to be perturbed during the ablation procedure. This
perturbation is probably imparted by peristalsis as suggested
in Figure 5. Peristalsis may have been triggered by deglutition
of secretions and/or barium.
It may be hypothesized that the patients in whom the po-
sition of the esophagus was stable over time are also the
ones in whom it does not shift acutely during the ablation
procedure. If this hypothesis were correct, esophageal stabil-
ity over many months should have only been documented in
one-third of the patients, because the esophagus was shown
to have shifted acutely in two-thirds of the patients in a prior
study.4 In contrast, the location of the esophagus was found
to be stable in >80% of the patients in the current study.
Left Atrial Volume
The LA volume at the repeat ablation procedure was 12%
smaller than at the initial procedure. One possible explanation
for a decrease in volume is a reverse remodeling due to
catheter ablation.8 However, the fact that most of the patients
Figure 5. Esophageal mobility due to peristalsis. A: A barium swallow in an AP projection shows that the esophagus lies along the mid-portion of the
posterior LA. Also seen are the ablation catheter, a catheter in the right atrium, and a ring catheter placed near the ostium of the left superior PV. The
dashed line shows the extent of the spinous processes as a reference. B: Shortly after commencing ablation, esophageal peristalsis was observed (solid
arrows) and the esophagus shifted to the right of the spinous processes (dashed line), posterior to the right-sided PV ostia. The dashed arrow indicates the
ablation catheter. C: Additional peristaltic movement of the esophagus. Also note the marked increase in the luminal diameter of the proximal esophagus.
The fluoroscopic projection is the same in all panels. CS = coronary sinus.
undergoing a repeat procedure presented in persistent atrial
fibrillation or flutter strongly argues against this hypothesis.
It is possible that the decrease in volume is due to LA scarring
and contraction due to multiple linear lesions.
Unfavorable LA/Esophageal Topography
Patients in whom the ablation procedure cannot be com-
pleted as planned because of the proximity of the esophagus
to a critical ablation site may be more likely to experience ar-
rhythmia recurrence and require a repeat ablation procedure.
Because the same limitation is likely to be present during the
second ablation procedure, it may be appropriate to consider a
different ablation technique, such as cryoablation. Cryoabla-
tion may be safer than radiofrequency energy because it tends
to preserve tissue architecture. However, experimental stud-
ies in animal models have arrived at conflicting conclusions
regarding the safety of cryoablation near the esophagus.9,10
Our current practice in these patients is to mechanically dis-
place the esophagus by inserting a rigid probe, as has been
reported previously.11 This allows safe radiofrequency abla-
tion without endangering the esophagus.
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Prior Studies
There are no prior studies concerning the temporal sta-
bility of the esophagus in patients undergoing LA ablation.
A previous study examined the relationship of the LA and
esophagus on computed tomography.12 However, whether
the anatomic relationship of the two structures is constant
over time was not explored.
Limitations
It is plausible that deglutition of barium or secretions may
have perturbed the intrinsic position of the esophagus by
induction of peristalsis. The smaller LA volume at the repeat
ablation procedure potentially may have made it difficult to
compare the location of the esophagus relative to the LA.
However, the distance between the esophagus and the PVs,
which generally was in the range of 2–4 cm, is unlikely to
have been affected by a small change in chamber volume.
Clinical Implications
The main clinical implication of the study is that if the
initial ablation procedure was hindered by the location of
the esophagus, the same limitation is likely to be present at
the repeat session. However, in nearly 20% of patients the
esophageal location is at least 1 cm removed from the origi-
nal position, making reevaluation of the esophagus necessary
during a repeat ablation procedure.
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